Skip to content
Review Open access

Isolated orofacial dystonia and facial pain as the inaugural manifestation of anti-NMDAR encephalitis: a case report and literature review

Jul 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 12 references
Medicine

TL;DR

A rare case of anti-NMDAR encephalitis in a 30-year-old female who presented with isolated left temporomandibular joint (TMJ) dystonia, jaw tremor, and facial pain as the sole manifestations for seven months, without clinically significant psychiatric, cognitive, or seizure symptoms is reported.

Abstract

Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis typically presents with psychiatric symptoms, seizures, and cognitive dysfunction. Movement disorders, when present, usually coexist with these features. We report a rare case of anti-NMDAR encephalitis in a 30-year-old female who presented with isolated left temporomandibular joint (TMJ) dystonia, jaw tremor, and facial pain as the sole manifestations for seven months, without clinically significant psychiatric, cognitive, or seizure symptoms. The patient was repeatedly misdiagnosed with TMJ disorder and muscular dysfunction before anti-NMDAR IgG antibodies were detected by cell-based assay (CBA) in serum (1:32) and cerebrospinal fluid (CSF, 1:1). First-line immunotherapy with intravenous immunoglobulin (IVIG) achieved remission. However, she relapsed five months later following COVID-19 infection, with antibody titers rising to 1:100 in both serum and CSF. High-dose corticosteroid pulse therapy and maintenance mycophenolate mofetil were administered, achieving sustained clinical improvement over four years of follow-up, although mild residual focal dystonia persisted. Whole-exome sequencing and hereditary ataxia screening excluded genetic causes. This case broadens the clinical spectrum of anti-NMDAR encephalitis and underscores the importance of early antibody testing in young patients with treatment-refractory orofacial movement disorders.

Read PDF

Similar papers

Case report Open access Sep 2026

Case Report: A case of anti-mGluR1 antibody-associated encephalitis treated with efgartigimod combined with rituximab

During disease progression, innovative sequential therapy with efgartigimod, an FcRn antagonist, was followed by the anti-CD20 monoclonal antibody rituximab (RTX) to reduce the risk of profound B-cell depletion, thereby demonstrating synergistic efficacy.

Jun-Tong Liu, Wen-Ping Zhu, Lan Gao et al. · 1 citation
Open access Oct 2026

Rapidly Evolving Aphasia as a Diagnostic Clue in First-Episode Psychosis: A Case Report of Anti-NMDAR Encephalitis.

Anti-N-methyl-D-aspartate receptor encephalitis frequently presents with isolated psychiatric symptoms indistinguishable from primary psychosis, delaying diagnosis. The authors have described a previously healthy 35-year-old woman admitted with abrupt first-episode psychosis, who (within 48 hours and without seizures,...

M. Basta, C. Bikis, A. Miliaras et al. · 0 citations
Case report Open access Sep 2026

Case report: Atypical anti-GlyR antibody-positive pediatric progressive encephalomyelitis with rigidity and myoclonus presenting as chronic joint pain

Progressive encephalomyelitis with rigidity and myoclonus (PERM) represents the most severe subtype of stiff-person spectrum disorders and is exceedingly rare in children. We report a 14-year-old female patient who presented with chronic joint pain and axial rigidity as the initial manifestations, with a disease course...

Xiao-Xue Zou, Lian Meng, Jin-Yu Huang et al. · 0 citations
Case report Open access Aug 2026

Case Report: Rare brainstem involvement in anti-metabotropic glutamate receptor 1 encephalitis

Findings support the possibility that anti-mGluR1 encephalitis may, in rare instances, present with predominant brainstem involvement and testing for anti-mGluR1 antibodies may be considered in patients with otherwise unexplained subacute inflammatory brainstem syndromes.

Mei-Jiao Hu, Heng Zhou, Xin Yi · 0 citations
Case report Open access Sep 2026

Nursing care of a pediatric patient with anti-NMDAR encephalitis complicated by secondary epilepsy

Rationale: Autoimmune encephalitis in children often presents with neuropsychiatric symptoms and seizures and may progress to secondary epilepsy with prolonged functional impairment. Immunotherapy is the principal disease-modifying treatment, whereas comprehensive nursing care supports safety, complication prevention,...

Qiong Huang, Lu-Yao Wang · 0 citations
Case report Open access Sep 2026

Neurocognitive sequelae following seronegative anti-NMDA receptor encephalitis with ovarian teratoma in a pediatric patient: A six-year follow-up case report

Background Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is the commonest form of autoimmune encephalitis of childhood. However, little information is captured with formal neuropsychological testing. When the pre-illness history is incomplete, it is also hard to judge how much of the residual picture reflects...

Felipe Dalvi-Garcia, Iolanda de Salles Fonseca Carvalho, Julia Valeriano de Almeida et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.